Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center

Background: The introduction of trastuzumab biosimilars in clinical practice plays an important role in promoting the sustainability of healthcare systems. By contrast, the switching process can be challenging to the clinics. This survey describes the switching process at a National Cancer Institute...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceutics
Main Authors: Piezzo, Michela, D’Aniello, Roberta, Avallone, Ilaria, Barba, Bruno, Cianniello, Daniela, Cocco, Stefania, D’Avino, Antonio, Di Gioia, Germira, Di Lauro, Vincenzo, Fusco, Giuseppina, Piscitelli, Raffaele, von Arx, Claudia, De Laurentiis, Michelino, Maiolino, Piera
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8151152/
https://ncbi.nlm.nih.gov/pubmed/34068626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13050684
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados